632 related articles for article (PubMed ID: 20370455)
1. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
[TBL] [Abstract][Full Text] [Related]
3. Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis.
Wang G; Lai FM; Tam LS; Li KM; Lai KB; Chow KM; Li KT; Szeto CC
J Rheumatol; 2007 Dec; 34(12):2358-64. PubMed ID: 17985404
[TBL] [Abstract][Full Text] [Related]
4. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.
Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM
Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-7 delays podocyte injury due to high glucose.
De Petris L; Hruska KA; Chiechio S; Liapis H
Nephrol Dial Transplant; 2007 Dec; 22(12):3442-50. PubMed ID: 17686813
[TBL] [Abstract][Full Text] [Related]
6. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia.
Garovic VD; Wagner SJ; Petrovic LM; Gray CE; Hall P; Sugimoto H; Kalluri R; Grande JP
Nephrol Dial Transplant; 2007 Apr; 22(4):1136-43. PubMed ID: 17255128
[TBL] [Abstract][Full Text] [Related]
7. Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li PK; Szeto CC
Eur J Endocrinol; 2008 Mar; 158(3):317-22. PubMed ID: 18299464
[TBL] [Abstract][Full Text] [Related]
8. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
[TBL] [Abstract][Full Text] [Related]
9. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
10. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
Chen LP; Zhou QL; Peng WS; Wu XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
[TBL] [Abstract][Full Text] [Related]
11. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
[TBL] [Abstract][Full Text] [Related]
12. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
13. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
14. Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models.
Kimura J; Ichii O; Otsuka S; Sasaki H; Hashimoto Y; Kon Y
Am J Nephrol; 2013; 38(1):27-38. PubMed ID: 23817053
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
16. Podocyte loss in human hypertensive nephrosclerosis.
Wang G; Lai FM; Kwan BC; Lai KB; Chow KM; Li PK; Szeto CC
Am J Hypertens; 2009 Mar; 22(3):300-6. PubMed ID: 19131934
[TBL] [Abstract][Full Text] [Related]
17. Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology.
Perysinaki GS; Moysiadis DK; Bertsias G; Giannopoulou I; Kyriacou K; Nakopoulou L; Boumpas DT; Daphnis E
Lupus; 2011 Jul; 20(8):781-91. PubMed ID: 21478284
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of nephrin according to glomerular size in early diabetic kidney disease.
Kim JJ; Li JJ; Jung DS; Kwak SJ; Ryu DR; Yoo TH; Han SH; Choi HY; Kim HJ; Han DS; Kang SW
J Am Soc Nephrol; 2007 Aug; 18(8):2303-10. PubMed ID: 17599973
[TBL] [Abstract][Full Text] [Related]
19. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
20. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]